Article
Interlesional Heterogeneity of EGFR Mutations: A Systematic Review and Meta-analysis.
Molecular diagnosis & therapy - 1 Mar 2026
Rodríguez Sánchez Diana Ivonne, Öztürk Selin Asli, Maxouri Olga, van der Mierden Stevie, Schats Winnie, Rostami Sajjad, Ursprung Stephan, Snaebjornsson Petur, Bodalal Zuhir, Beets-Tan Regina
Abstract excerpt
BACKGROUND: Activating epidermal growth factor receptor (EGFR) mutations are key drivers in non-small cell lung cancer (NSCLC) and other solid tumours, predicting responses to tyrosine kinase inhibitors (TKIs). Tumour heterogeneity alongside sampling and technical factors may contribute to discordant EGFR status across biopsies, complicating treatment decisions. However, systematic evidence on prevalence and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
